{"transactions":[{"id":1047419,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":28.99,"value":2899.0,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2903931,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047418,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":28.96,"value":2896.0,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2904031,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047417,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":30105,"price":28.24,"value":850165.2,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2904131,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047416,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":69695,"price":27.6,"value":1923582.0,"ownership":{"direct":false,"nature":"By Chaming Jade Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2934236,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1119072,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-06T21:00:34.000Z","date":"2025-06-05","kind":"grant","planned":true,"acquired":true,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":24165,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0000950170-25-083239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017025083239/ownership.xml","form_type":"4"}},{"id":1327703,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T23:03:16.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":700000,"price":28,"value":19600000.0,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were offered and sold by Charming Jade Limited in connection with the Issuer's public offering pursuant to the Registration Statement on Form S-1 (File No. 333-283725) that closed on December 16, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":3003931,"source":{"system":"sec-edgar","filing":"0001415889-24-029664","document":"form4-12172024_111213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000141588924029664/form4-12172024_111213.xml","form_type":"4"}},{"id":1389821,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T21:03:59.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":15600,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0000950170-24-113304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024113304/ownership.xml","form_type":"4"}},{"id":1418712,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T23:18:39.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":226245,"price":35.36,"value":8000023.2,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P."}],"balance_after":3703931,"source":{"system":"sec-edgar","filing":"0000950170-24-102496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024102496/ownership.xml","form_type":"4"}},{"id":1418711,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T23:18:39.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":424210,"price":35.36,"value":15000065.6,"ownership":{"direct":false,"nature":"By Unique Diamond Investments Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":586982,"source":{"system":"sec-edgar","filing":"0000950170-24-102496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024102496/ownership.xml","form_type":"4"}},{"id":1664757,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E  Preferred Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":37474236,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed\nLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to\nshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their\npecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3930176},"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664756,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D  Preferred Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":3378758,"ownership":{"direct":false,"nature":"By Unique Diamond Investments Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund,\nL.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed\nLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to\nshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their\npecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":354353},"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664755,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C  Preferred Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":6262967,"ownership":{"direct":false,"nature":"By Unique Diamond Investments Limited"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund,\nL.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed\nLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to\nshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their\npecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":656839},"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664754,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B  Preferred Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":3344608,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":350771},"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664753,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":263157,"price":19,"value":4999983.0,"ownership":{"direct":true},"balance_after":613928,"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664752,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":3930176,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed\nLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to\nshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their\npecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P."}],"balance_after":3930176,"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664751,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":1011192,"ownership":{"direct":false,"nature":"By Unique Diamond Investments Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund,\nL.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed\nLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to\nshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their\npecuniary interests therein."}],"balance_after":1011192,"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}},{"id":1664750,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:30:07.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":350771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred\nstock automatically converted into common stock upon the closing of the Issuer's initial public offering."}],"balance_after":350771,"source":{"system":"sec-edgar","filing":"0000950170-24-009429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000095017024009429/ownership.xml","form_type":"4"}}]}